Authors



Bradley Burk, PharmD, BCPP

Latest:

Educational Resources to Support Patients

Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.


Luis A. Valcarcel, PharmD Candidate

Latest:

Changing the Game: Pharmacy Students' Perspective on Naloxone OTC Approval

To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.



Stephanie Ostling Mason, PharmD, CDCES

Latest:

New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic Management

The measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians.


Aric Logsdon, PhD

Latest:

Topical Ketamine: A Promising New Avenue for PTSD Treatment

Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.


Jacob Coomes, PharmD

Latest:

Empowering Diabetes Care: The Evolving Role of Pharmacists

Pharmacists are well-positioned to address diabetes from a multifaceted approach.


Crystal Toribio, PharmD

Latest:

Going Back to the Basics: An Asthma Review

A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.


Diana Roskova

Latest:

Pain Management in the ICU Is Complex

Finding the right medication or drug combination for individual patients is critical.


Michael Leighton, PharmD, MBA

Latest:

Proposed FDA Rule on Patient Medication Information Seeks to Address Prescription Misuse, Nonadherence

Improved prescription information could help consumers make better health care decisions and result in cost savings.


Ali S. Abud

Latest:

Mandatory Immunization of Health Care Workers Leads to Controversy

Legal issues surfaced once again with the COVID-19 pandemic


Susan W. Lanham, PhD, MAFF, CDFA

Latest:

Gabapentin Presents High Potential for Misuse

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.


Ashley Sauro, PharmD, BCPS

Latest:

Implementing USP <800> Guidelines in Pediatric Hospitals

Protecting this vulnerable patient population requires specially designed strategies.


Abbey M. Natour

Latest:

Respect State Marijuana Laws Act of 2017 Amends Previous Legislation

Past proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.


Mansi Patel, OMS-II

Latest:

Considerations for RSV Prevention in Special Patient Populations

Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.


Krysta Larson, PharmD

Latest:

Brexanolone and Zuranolone for the Treatment of Postpartum Depression

The American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.


Arefa Bacchus, PharmD

Latest:

Reduced POMP Dosing Shows Comparable Efficacy in ALL Maintenance

Arefa Bacchus, PharmD shared key insights about the use of POMP therapy in patients with acute lymphoblastic leukemia (ALL).


Miriam Haddad, PharmD

Latest:

Pharmacists Play a Crucial Role When Addressing Health Literacy

Providers who are sensitive to health literacy have contributed to positive quality improvement across various institutions.


Hovsep Kirikian

Latest:

From Shortages to Solutions: Enhancing Drug Manufacturing Through Innovation

Technology and regulations can revolutionize drug manufacturing and ensure a stable supply of medications.


Verona Abdelmeseh, PharmD

Latest:

Overview of PARP Inhibitors in the Treatment of Ovarian Cancer

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.


Mya Tran, PharmD, BCOP

Latest:

Combination Therapies and Resistance-Based Approaches Reshape EGFR Care

Mya Tran, PharmD, BCOP, offers insights for navigating the complex treatment landscape for non-small cell lung cancer.


Rachel Cormier

Latest:

PQA Annual Meeting: Quality Emerges from the Pandemic, Focused on Access and Equity

Open to all health care professionals, the PQA meeting is a top forum for learning best practices and emerging trends in medication services, pharmacist-provided care and quality improvement initiatives.


Shannon Reidt, PharmD, MPH, MS

Latest:

Team-Based Care: How Pharmacists Can Expand Patient Access to Health Care

However, comprehensive policy and payment structures are needed to ensure care sustainability.


Amy Spigelmyer, PharmD, BCIDP

Latest:

Pharmacists Are Key Players in C difficile Infection Prevention

Pharmacists can promote prevention through the implementation of antimicrobial stewardship initiatives and advocate for fecal microbiota transplant.


Carlie Traylor, PharmD

Latest:

NCPA Fellowship Allows Pharmacists to Choose Their Own Adventure

Fellows tap into a network of experts, their practice sites, and countless tools they can apply immediately.


Jude Sammani, PharmD Candidate

Latest:

Considerations for Tacrolimus in Pregnant Patients with a History of Organ Transplantation

Tacrolimus is a selective calcineurin inhibitor that exerts inhibitory effects on T-cell proliferation.


Jill Simonian, PharmD

Latest:

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

In this episode, Jill Simonian and Codi Peterson explore the evolving role of pharmacists in medical cannabis, addressing legal complexities, patient counseling, and key considerations for safe and effective use.


Melody Chang, MBA, RPh, BCOP

Latest:

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.


Kelsey E. Norman, PharmD, BCCP, BCACP, BCPS

Latest:

Guideline Recommendations for LDL-C Management

Panelists discuss how evolving clinical guidelines for intensive low-density lipoprotein cholesterol (LDL-C)–lowering therapies have shaped personalized treatment approaches through risk stratification, with different targets for primary vs secondary prevention and consideration of genetic factors when determining appropriate statin intensity.


Lisa Thompson, RPT, CPhT, BS

Latest:

Technicians Are Crucial to Managing the Flow of an Independent Pharmacy

During a time of staff shortages and increasing stress, the need to have an efficient workflow is of vital importance.